MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202527104407 A) filed by Shanghai Hansoh Biomedical Co. , Ltd.; and Changzhou Hansoh Pharmaceutical Co. on October 29, 2025, for Antibody Or Antigen-Binding Fragment Thereof, Antibody-Drug Conjugate, And Use Thereof.
Inventors include Chen, Simeng Number; Wang, Leilei; and Zhang, Wei.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: The present invention relates to an antibody or an antigen-binding fragment thereof, an antibody-drug conjugate thereof, and the use thereof. Specifically, provided in the present invention are an SEZ6 antibody, an antigen-binding fragment thereof, an SEZ6 antibody- drug conjugate, a nucleic acid molecule encoding the antibody, an antigen-binding fragment thereof, a vector and host cell containing the nucleic acid molecule, and a method for preparing an antibody-coupled toxin. Also provided are a pharmaceutical composition containing the antibody, the antigen-binding fragment thereof, or the antibody-coupled toxin, and the related pharmaceutical use.
Disclaimer: Curated by HT Syndication.
